Immunotherapy of metastatic melanoma with interleukin-2.
Paciucci
P A
PA
Jeanne B. Lambert Laboratory for Cancer Research, Mount Sinai School of Medicine, New York, NY 10029.
D000328:Adult; D000368:Aged; D017024:Chemotherapy, Adjuvant; D004306:Dose-Response Relationship, Immunologic; D005260:Female; D006801:Humans; D016219:Immunotherapy, Adoptive; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008545:Melanoma / Q000556:secondary / Q000628:therapy*; D008875:Middle Aged; D011379:Prognosis
D007376:Interleukin-2